Zoekresultaten - Zakowski, Maureen F.

Verfijn jouw resultaten
  1. 1
    Metastatic Medullary Thyroid Carcinoma and Cabozantinib: Case Series and Review of Literature

    Metastatic Medullary Thyroid Carcinoma and Cabozantinib: Case Series and Review of Literature door Kapur, Sakshi, Xiao, Han, Zakowski, Maureen F., Hameed, Meera R., Levin, Miles B.

    Gepubliceerd in 2014
    Volledige tekst Volledige tekst Volledige tekst
    Text
    Toevoegen aan favorieten
    Bewaard in:
  2. 2
    Lung adenocarcinomas induced in mice by mutant EGF receptors foundin human lung cancers respondto a tyrosine kinase inhibitor orto down-regulation of the receptors

    Lung adenocarcinomas induced in mice by mutant EGF receptors foundin human lung cancers respondto a tyrosine kinase inhibitor orto down-regulation of the receptors door Politi, Katerina, Zakowski, Maureen F., Fan, Pang-Dian, Schonfeld, Emily A., Pao, William, Varmus, Harold E.

    Gepubliceerd in 2006
    Volledige tekst Volledige tekst Volledige tekst
    Text
    Toevoegen aan favorieten
    Bewaard in:
  3. 3
    Reflex testing of resected stage I-III lung adenocarcinomas for EGFR and KRAS mutation, report on initial experience and clinical utility at a single center

    Reflex testing of resected stage I-III lung adenocarcinomas for EGFR and KRAS mutation, report on initial experience and clinical utility at a single center door D’Angelo, Sandra P., Park, Bernard, Azzoli, Christopher G., Kris, Mark G., Rusch, Valerie, Ladanyi, Marc, Zakowski, Maureen F.

    Gepubliceerd in 2011
    Volledige tekst Volledige tekst Volledige tekst
    Text
    Toevoegen aan favorieten
    Bewaard in:
  4. 4
    Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain

    Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain door Pao, William, Miller, Vincent A, Politi, Katerina A, Riely, Gregory J, Somwar, Romel, Zakowski, Maureen F, Kris, Mark G, Varmus, Harold

    Gepubliceerd in 2005
    Volledige tekst Volledige tekst Volledige tekst
    Text
    Toevoegen aan favorieten
    Bewaard in:
  5. 5
    Core Needle Lung Biopsy Specimens: Adequacy for EGFR and KRAS Mutational Analysis

    Core Needle Lung Biopsy Specimens: Adequacy for EGFR and KRAS Mutational Analysis door Solomon, Stephen B., Zakowski, Maureen F., Pao, William, Thornton, Raymond H., Ladanyi, Marc, Kris, Mark G., Rusch, Valerie W., Rizvi, Naiyer A.

    Gepubliceerd in 2010
    Volledige tekst Volledige tekst Volledige tekst
    Text
    Toevoegen aan favorieten
    Bewaard in:
  6. 6
    Morphologic Features of Adenocarcinoma of the Lung Predictive of Response to the Epidermal Growth Factor Receptor Kinase Inhibitors Erlotinib and Gefitinib

    Morphologic Features of Adenocarcinoma of the Lung Predictive of Response to the Epidermal Growth Factor Receptor Kinase Inhibitors Erlotinib and Gefitinib door Zakowski, Maureen F., Hussain, Sanaa, Pao, William, Ladanyi, Marc, Ginsberg, Michelle S., Heelan, Robert, Miller, Vincent A., Rusch, Valerie W., Kris, Mark G.

    Gepubliceerd in 2009
    Volledige tekst Volledige tekst Volledige tekst
    Text
    Toevoegen aan favorieten
    Bewaard in:
  7. 7
    EGFR Mutations in Lung Adenocarcinomas: Clinical Testing Experience and Relationship to EGFR Gene Copy Number and Immunohistochemical Expression

    EGFR Mutations in Lung Adenocarcinomas: Clinical Testing Experience and Relationship to EGFR Gene Copy Number and Immunohistochemical Expression door Li, Allan R., Chitale, Dhananjay, Riely, Gregory J., Pao, William, Miller, Vincent A., Zakowski, Maureen F., Rusch, Valerie, Kris, Mark G., Ladanyi, Marc

    Gepubliceerd in 2008
    Volledige tekst Volledige tekst Volledige tekst
    Text
    Toevoegen aan favorieten
    Bewaard in:
  8. 8
    EGFR Exon 20 Insertion Mutations in Lung Adenocarcinomas: Prevalence, Molecular Heterogeneity, and Clinicopathologic Characteristics

    EGFR Exon 20 Insertion Mutations in Lung Adenocarcinomas: Prevalence, Molecular Heterogeneity, and Clinicopathologic Characteristics door Arcila, Maria E, Nafa, Khedoudja, Chaft, Jamie E, Rekhtman, Natasha, Lau, Christopher, Reva, Boris A, Zakowski, Maureen F, Kris, Mark G, Ladanyi, Marc

    Gepubliceerd in 2013
    Volledige tekst Volledige tekst Volledige tekst
    Text
    Toevoegen aan favorieten
    Bewaard in:
  9. 9
    Correlation between tumor measurement on Computed Tomography and resected specimen size in lung adenocarcinomas

    Correlation between tumor measurement on Computed Tomography and resected specimen size in lung adenocarcinomas door Lampen-Sachar, Katharine, Zhao, Binsheng, Zheng, Junting, Moskowitz, Chaya S, Schwartz, Lawrence H, Zakowski, Maureen F, Rizvi, Naiyer A, Kris, Mark G, Ginsberg, Michelle S

    Gepubliceerd in 2011
    Volledige tekst Volledige tekst Volledige tekst
    Text
    Toevoegen aan favorieten
    Bewaard in:
  10. 10
    Development of New Mouse Lung Tumor Models Expressing EGFR T790M Mutants Associated with Clinical Resistance to Kinase Inhibitors

    Development of New Mouse Lung Tumor Models Expressing EGFR T790M Mutants Associated with Clinical Resistance to Kinase Inhibitors door Regales, Lucia, Balak, Marissa N., Gong, Yixuan, Politi, Katerina, Sawai, Ayana, Le, Carl, Koutcher, Jason A., Solit, David B., Rosen, Neal, Zakowski, Maureen F., Pao, William

    Gepubliceerd in 2007
    Volledige tekst Volledige tekst Volledige tekst
    Text
    Toevoegen aan favorieten
    Bewaard in:
  11. 11
    Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR TKI therapy in 155 patients with EGFR mutant Lung Cancers

    Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR TKI therapy in 155 patients with EGFR mutant Lung Cancers door Yu, Helena A., Arcila, Maria E., Rekhtman, Natasha, Sima, Camelia S., Zakowski, Maureen F., Pao, William, Kris, Mark G., Miller, Vincent A., Ladanyi, Marc, Riely, Gregory J.

    Gepubliceerd in 2013
    Volledige tekst Volledige tekst Volledige tekst
    Text
    Toevoegen aan favorieten
    Bewaard in:
  12. 12
    Prevalence, clinicopathologic associations and molecular spectrum of ERBB2 (HER2) tyrosine kinase mutations in lung adenocarcinomas

    Prevalence, clinicopathologic associations and molecular spectrum of ERBB2 (HER2) tyrosine kinase mutations in lung adenocarcinomas door Arcila, Maria E, Chaft, Jamie E, Nafa, Khedoudja, Roy-Chowdhuri, Sinchita, Lau, Christopher, Zaidinski, Michael, Paik, Paul K, Zakowski, Maureen F, Kris, Mark G, Ladanyi, Marc

    Gepubliceerd in 2012
    Volledige tekst Volledige tekst Volledige tekst
    Text
    Toevoegen aan favorieten
    Bewaard in:
  13. 13
    KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib

    KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib door Pao, William, Wang, Theresa Y, Riely, Gregory J, Miller, Vincent A, Pan, Qiulu, Ladanyi, Marc, Zakowski, Maureen F, Heelan, Robert T, Kris, Mark G, Varmus, Harold E

    Gepubliceerd in 2005
    Volledige tekst Volledige tekst Volledige tekst
    Text
    Toevoegen aan favorieten
    Bewaard in:
  14. 14
    Morphologic Accuracy in Differentiating Primary Lung Adenocarcinoma From Squamous Cell Carcinoma in Cytology Specimens

    Morphologic Accuracy in Differentiating Primary Lung Adenocarcinoma From Squamous Cell Carcinoma in Cytology Specimens door Zakowski, Maureen F., Rekhtman, Natasha, Auger, Manon, Booth, Christine N., Crothers, Barbara, Ghofrani, Mohiddean, Khalbuss, Walid, Laucirica, Rodolfo, Moriarty, Ann T., Tabatabai, Z. Laura, Barkan, Güliz A.

    Gepubliceerd in 2016
    Volledige tekst Volledige tekst Volledige tekst
    Text
    Toevoegen aan favorieten
    Bewaard in:
  15. 15
    High Expression Levels of Total IGF-1R and Sensitivity of NSCLC Cells In Vitro to an Anti-IGF-1R Antibody (R1507)

    High Expression Levels of Total IGF-1R and Sensitivity of NSCLC Cells In Vitro to an Anti-IGF-1R Antibody (R1507) door Gong, Yixuan, Yao, Evelyn, Shen, Ronglai, Goel, Aviva, Arcila, Maria, Teruya-Feldstein, Julie, Zakowski, Maureen F., Frankel, Stanley, Peifer, Martin, Thomas, Roman K., Ladanyi, Marc, Pao, William

    Gepubliceerd in 2009
    Volledige tekst Volledige tekst Volledige tekst
    Text
    Toevoegen aan favorieten
    Bewaard in:
  16. 16
    Rebiopsy of Lung Cancer Patients with Acquired Resistance to EGFR Inhibitors and Enhanced Detection of the T790M Mutation Using a Locked Nucleic Acid-Based Assay

    Rebiopsy of Lung Cancer Patients with Acquired Resistance to EGFR Inhibitors and Enhanced Detection of the T790M Mutation Using a Locked Nucleic Acid-Based Assay door Arcila, Maria E., Oxnard, Geoffrey R., Nafa, Khedoudja, Riely, Gregory J., Solomon, Stephen B., Zakowski, Maureen F., Kris, Mark G., Pao, William, Miller, Vincent A., Ladanyi, Marc

    Gepubliceerd in 2011
    Volledige tekst Volledige tekst Volledige tekst
    Text
    Toevoegen aan favorieten
    Bewaard in:
  17. 17
    Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor epidermal growth factor receptor (EGFR) mutations

    Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor epidermal growth factor receptor (EGFR) mutations door Janjigian, Yelena Y., Park, Bernard J., Zakowski, Maureen F., Ladanyi, Marc, Pao, William, D’Angelo, Sandra P., Kris, Mark G., Shen, Ronglai, Zheng, Junting, Azzoli, Christopher G.

    Gepubliceerd in 2011
    Volledige tekst Volledige tekst Volledige tekst
    Text
    Toevoegen aan favorieten
    Bewaard in:
  18. 18
    Clarifying the spectrum of driver oncogene mutations in biomarker-verified squamous carcinoma of lung: lack of EGFR/KRAS and presence of PIK3CA/AKT1 mutations

    Clarifying the spectrum of driver oncogene mutations in biomarker-verified squamous carcinoma of lung: lack of EGFR/KRAS and presence of PIK3CA/AKT1 mutations door Rekhtman, Natasha, Paik, Paul K., Arcila, Maria E., Tafe, Laura J., Oxnard, Geoffrey R., Moreira, Andre L., Travis, William D., Zakowski, Maureen F., Kris, Mark G., Ladanyi, Marc

    Gepubliceerd in 2012
    Volledige tekst Volledige tekst Volledige tekst
    Text
    Toevoegen aan favorieten
    Bewaard in:
  19. 19
    Response to Cabozantinib in Patients with RET Fusion-Positive Lung Adenocarcinomas

    Response to Cabozantinib in Patients with RET Fusion-Positive Lung Adenocarcinomas door Drilon, Alexander, Wang, Lu, Hasanovic, Adnan, Suehara, Yoshiyuki, Lipson, Doron, Stephens, Phil, Ross, Jeffrey, Miller, Vincent, Ginsberg, Michelle, Zakowski, Maureen F., Kris, Mark G., Ladanyi, Marc, Rizvi, Naiyer

    Gepubliceerd in 2013
    Volledige tekst Volledige tekst Volledige tekst
    Text
    Toevoegen aan favorieten
    Bewaard in:
  20. 20
    Incidence of EGFR Exon 19 Deletions and L858R in Tumor Specimens From Men and Cigarette Smokers With Lung Adenocarcinomas

    Incidence of EGFR Exon 19 Deletions and L858R in Tumor Specimens From Men and Cigarette Smokers With Lung Adenocarcinomas door D'Angelo, Sandra P., Pietanza, M. Catherine, Johnson, Melissa L., Riely, Gregory J., Miller, Vincent A., Sima, Camelia S., Zakowski, Maureen F., Rusch, Valerie W., Ladanyi, Marc, Kris, Mark G.

    Gepubliceerd in 2011
    Volledige tekst Volledige tekst Volledige tekst
    Text
    Toevoegen aan favorieten
    Bewaard in:

Zoekinstrumenten: